Abstract
We have previously shown in patients after recovery from a myocardial infarct (post-MI) that the heparin neutralizing activity (HNA) in the plasma is raised and that this activity may come from platelet factor 4 derived from activated platelets. This report concerns 89 patients admitted with acute chest pain; in 54, with evidence of acute infarction, the level of HNA is much higher than in a post-MI group or controls. Over the ensuing weeks the HNA decreases to the post-MI level. In 34 patients the evidence subsequently collected excluded a diagnosis of infarction; in these there were almost always normal amounts of HNA and little overlap with the results from the patients with infarcts. This easy test is therefore likely to prove clinically useful. Its significance is discussed. The platelet count and platelet volume are both abnormal in patients with acute infarction and also in the chest pain group so these tests do not help to discriminate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cotton R. C., Bloor K., Archibald G. Inter-relationships between platelet response to adenosine diphosphate, blood coagulation and serum lipids in patients with peripheral occlusive atherosclerosis. Atherosclerosis. 1972 Nov-Dec;16(3):337–348. doi: 10.1016/0021-9150(72)90081-0. [DOI] [PubMed] [Google Scholar]
- Farbiszewski R., Niewiarowski S., Worowski K., Lipiński B. Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states. Thromb Diath Haemorrh. 1968 Jul 31;19(3):578–583. [PubMed] [Google Scholar]
- Fuster V., Bowie E. J., Kazmier F. J., Owen C. A., Jr Platelet consumption in chronically induced plasma platelet factor 4-like activity reflecting rate of intravascular coagulation in dogs. Thromb Res. 1974 Feb;4(2):247–260. doi: 10.1016/0049-3848(74)90090-5. [DOI] [PubMed] [Google Scholar]
- GORMSEN J. A technique for the heparin-tolerance test. Br J Haematol. 1959 Jul;5:257–267. doi: 10.1111/j.1365-2141.1959.tb04033.x. [DOI] [PubMed] [Google Scholar]
- HOLGER-MADSEN T. Reduction of heparin activity by plasma globulins in patients with increased heparin resistance. Acta Haematol. 1962;27:157–170. doi: 10.1159/000206777. [DOI] [PubMed] [Google Scholar]
- O'Brien J. R. Anti-thormbin III and heparin clotting times in thrombosis and atherosclerosis. Thromb Diath Haemorrh. 1974 Sep 30;32(1):116–123. [PubMed] [Google Scholar]
- O'Brien J. R., Etherington M., Jamieson S., Klaber M. R., Lincoln S. V. Platelet function long after arterial and venous thrombosis. Thromb Diath Haemorrh. 1974 May 15;31(2):279–290. [PubMed] [Google Scholar]
- O'Brien J. R., Etherington M., Jamieson S., Lawford P. Letter: Heparin thrombin clotting-time and platelet factor 4. Lancet. 1974 Sep 14;2(7881):656–657. doi: 10.1016/s0140-6736(74)91982-5. [DOI] [PubMed] [Google Scholar]
- Ogura J. H., Fetter N. R., Blankenhorn M. A., Glueck H. I. CHANGES IN BLOOD COAGULATION FOLLOWING CORONARY THROMBOSIS MEASURED BY THE HEPARIN RETARDED CLOTTING TEST (WAUGH AND RUDDICK TEST). J Clin Invest. 1946 Jul;25(4):586–596. doi: 10.1172/JCI101741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROSENTHAL R. L., WEAVER J. C., BENEDEK A. Acceleration of blood coagulation in acute myocardial infarction as demonstrated by the heparin clotting time; effect of dicumarol therapy. Circulation. 1952 Aug;6(2):257–261. doi: 10.1161/01.cir.6.2.257. [DOI] [PubMed] [Google Scholar]